232 related articles for article (PubMed ID: 26298505)
1. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
[TBL] [Abstract][Full Text] [Related]
2. Positive perception of pharmacogenetic testing for psychotropic medications.
Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.
Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ
Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889
[TBL] [Abstract][Full Text] [Related]
4. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
Fan M; Bousman CA
Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
[TBL] [Abstract][Full Text] [Related]
6. Psychiatrist attitudes towards pharmacogenetic testing, direct-to-consumer genetic testing, and integrating genetic counseling into psychiatric patient care.
Thompson C; Steven P Hamilton ; Catriona Hippman
Psychiatry Res; 2015 Mar; 226(1):68-72. PubMed ID: 25618469
[TBL] [Abstract][Full Text] [Related]
7. Patients' and physicians' perspectives on pharmacogenetic testing.
Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
[TBL] [Abstract][Full Text] [Related]
8. Personalized pharmacotherapy in psychiatry.
Filaković P; Petek A
Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
[TBL] [Abstract][Full Text] [Related]
9. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
[No Abstract] [Full Text] [Related]
10. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
Hoop JG; Lapid MI; Paulson RM; Roberts LW
J Clin Psychiatry; 2010 Jun; 71(6):745-53. PubMed ID: 20361898
[TBL] [Abstract][Full Text] [Related]
11. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.
Müller DJ; Kekin I; Kao AC; Brandl EJ
Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801
[TBL] [Abstract][Full Text] [Related]
12. Counselling patients on psychotropic medication: physicians' opinions on the role of community pharmacists.
Tanskanen P; Airaksinen M; Tanskanen A; Enlund H
Pharm World Sci; 2000 Apr; 22(2):59-61. PubMed ID: 10849924
[TBL] [Abstract][Full Text] [Related]
13. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
[TBL] [Abstract][Full Text] [Related]
14. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
15. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
[TBL] [Abstract][Full Text] [Related]
16. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.
Korošec Hudnik L; Blagus T; Redenšek Trampuž S; Dolžan V; Bon J; Pjevac M
Front Psychiatry; 2024; 15():1363051. PubMed ID: 38566958
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
Shishko I; Almeida K; Silvia RJ; Tataronis GR
Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
[TBL] [Abstract][Full Text] [Related]
18. Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
de Leon J
Pharmacogenomics; 2021 Aug; 22(13):805-808. PubMed ID: 34344160
[No Abstract] [Full Text] [Related]
19. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
Sychev D; Fedina L; Poptsova M; Zateyshchikov D; Mirzaev K; Tsimbal E; Sychev I; Rastvorova T
Pharmacogenomics; 2022 Oct; 23(15):847-856. PubMed ID: 36093937
[No Abstract] [Full Text] [Related]
20. Psychiatric medication preferences of sports psychiatrists.
Reardon CL; Creado S
Phys Sportsmed; 2016 Nov; 44(4):397-402. PubMed ID: 27463033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
